Improve the Quality of Life After a Hospitalization in Critical Care

CompletedOBSERVATIONAL
Enrollment

1,006

Participants

Timeline

Start Date

October 1, 2015

Primary Completion Date

October 31, 2016

Study Completion Date

December 31, 2016

Conditions
DepressionDepression Symptoms
Interventions
OTHER

experimental

corresponding to surviving individuals of a hospitalization in intensive care in a department having set up the program of reduction of the discomforts collected by the patients of intensive care during a minimal period of 5 months. The program is so defined as factor of exposure and supposed protector of development of anxio-depressive disorders.These patients will have been included in the study IPREA3 in 17 centers of the interventional group of the study IPREA3 during the months of April, 2015 and October, 2015

OTHER

control

"The patients not exposed in the supposed factor protector of development of anxio-depressive disorders will be constituted by the patients estimated in the study IPREA3 corresponding to surviving individuals of a hospitalization in intensive care in a department having never operated the program of reduction of the discomforts collected by the patients of intensive care. These patients will have been included in the study IPREA3 in 17 centers of the group control some study IPREA3 during October 2014 and April, 2015"

Trial Locations (12)

10000

CH Troyes, Troyes

17022

CH La Rochelle, La Rochelle

28018

C.H. de Chartres, Chartres

43000

CH Le Puy en Velay, Le Puy-en-Velay

59507

CH Douai, Douai

62300

CH Lens, Lens

67000

CHU NHC, Strasbourg

67100

CHU Hautepierre, Strasbourg

69003

CHU Edouard Herriot, Lyon

75010

CHU Saint Louis APHP, Paris

75014

CHU Cochin APHP, Paris

92110

CHU Beaujon APHP, Clichy

All Listed Sponsors
lead

Centre Hospitalier of Chartres

OTHER

NCT02762409 - Improve the Quality of Life After a Hospitalization in Critical Care | Biotech Hunter | Biotech Hunter